Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study
Janjigian, Y. Y., Kawazoe, A., Yanez, P. E., Luo, S. X., Lonardi, S., Kolesnik, O., . . . Tabernero, J., … Read More
